Kathmere Capital Management LLC acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 841 shares of the company's stock, valued at approximately $291,000.
Other hedge funds have also modified their holdings of the company. Atwood & Palmer Inc. purchased a new stake in shares of HCA Healthcare in the first quarter valued at about $28,000. Bartlett & CO. Wealth Management LLC lifted its position in HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after acquiring an additional 80 shares during the period. Tidemark LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter worth approximately $36,000. ORG Partners LLC grew its position in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares during the last quarter. Finally, Legacy Investment Solutions LLC lifted its stake in shares of HCA Healthcare by 99.0% in the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after acquiring an additional 95 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of equities research analysts have weighed in on HCA shares. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Guggenheim assumed coverage on HCA Healthcare in a research report on Wednesday, April 9th. They issued a "neutral" rating for the company. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Finally, Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Seven investment analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.
Get Our Latest Report on HCA Healthcare
Insiders Place Their Bets
In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.
HCA Healthcare Trading Up 1.2%
NYSE:HCA traded up $4.36 on Monday, reaching $380.43. The stock had a trading volume of 935,591 shares, compared to its average volume of 1,587,036. The firm's fifty day moving average is $375.13 and its two-hundred day moving average is $342.25. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The company has a market cap of $91.52 billion, a price-to-earnings ratio of 16.92, a P/E/G ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.
HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. HCA Healthcare's revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $5.36 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Monday, June 30th. Investors of record on Monday, June 16th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.76%. HCA Healthcare's dividend payout ratio is presently 12.81%.
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.